Can higher arachidonic acid levels sustain low-grade inflammatory signaling?

Arachidonic acid (AA) acts as a foundational component of the cellular inflammatory response. While essential for normal physiological function, its role as a primary substrate for bioactive lipids makes it a central driver of sustained inflammatory signaling when present in higher concentrations.

Mechanistic basis of inflammation

AA is a 20-carbon polyunsaturated fatty acid primarily stored in cell membrane phospholipids. It is liberated by the enzyme phospholipase A2 (PLA2) in response to stimuli like injury or oxidative stress. Once free, AA enters several key enzymatic pathways:

• Cyclooxygenase (COX-1/2) pathway: Converts AA into prostanoids, specifically prostaglandin E2 (PGE2) and thromboxane A2 (TXA2). PGE2 is a potent mediator of vasodilation, pain, and fever, while TXA2 drives platelet aggregation.
• Lipoxygenase (LOX) pathway: Processes AA into leukotrienes, such as LTB4, which acts as a powerful chemoattractant for neutrophils and exacerbates tissue inflammation.
• Pro-inflammatory cascade: These metabolites trigger secondary signals, including the release of cytokines like interleukin-1β (IL-1β) and tumor necrosis factor-alpha (TNF-α), which reinforce the inflammatory state.

Clinical evidence and low-grade signaling

Higher levels of AA, often measured in erythrocyte membranes or adipose tissue, are correlated with markers of systemic low-grade inflammation.

• Biomarker associations: Elevated AA levels are linked to increased C-reactive protein (CRP), a hallmark of systemic inflammation.
• Metabolic and age-related factors: In middle-aged and post-menopausal populations, this relationship is often exacerbated by metabolic stressors. Research indicates that increased body mass index (BMI) can promote AA accumulation in adipose tissue, further sustaining chronic, low-grade inflammatory signaling through the continuous production of PGE2 and leukotrienes.
• Chronic disease links: Dysregulation of this "arachidonate cascade" is a recognized mechanism in the development of chronic conditions, including cardiovascular disease and metabolic syndrome.

Bottom line

Arachidonic acid is the essential substrate for pro-inflammatory eicosanoids. High levels can sustain low-grade inflammatory signaling by providing a constant supply of precursors for prostaglandins and leukotrienes, particularly in the context of aging and metabolic stress.